Lung production of platelet-activating factor acetylhydrolase in oleic acid-induced acute lung injury

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 77, Issue 1, 2007, Pages 1-8

  Salluh, Jorge I ^a,b   Pino, Alexandre V ^c   Silva, Adriana R ^a   Gomes, Rachel N ^a   Souza, Heitor S ^c   e Silva, Jose Roberto Lapa ^c   Jandre, Frederico C ^c   Giannella Neto, Antonio ^c   Zimmerman, Guy A ^d   Stafforini, Diana M ^e   Prescott, Stephen M ^e   Castro Faria Neto, Hugo C ^a   Bozza, Patrícia T ^a   Bozza, Fernando A ^a,f  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF UTAH   (United States)

^f Funda??o Oswaldo Cruz   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; OLEIC ACID;

ACUTE LUNG INJURY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME KINETICS; ENZYME SYNTHESIS; FEMALE; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS EPITHELIUM; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; LUNG PARENCHYMA; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; SWINE;

1-ALKYL-2-ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; FEMALE; IMMUNOHISTOCHEMISTRY; KINETICS; LUNG; OLEIC ACID; RESPIRATORY DISTRESS SYNDROME, ADULT; SWINE; TIME FACTORS;

ANIMALIA; SUIDAE;

EID: 34547851817     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2007.04.001     Document Type: Article

References (27)

1. Stafforini D.M., McIntyre T.M., Zimmerman G.A., and Prescott S.M. Platelet-activating factor, a pleiotrophic mediator of physiological and pathological processes. Crit. Rev. Clin. Lab. Sci. 40 (2003) 643-672
2. Zimmerman G.A., McIntyre T.M., Prescott S.M., and Stafforini D.M. The platelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosis. Crit. Care Med. 30 (2002) S294-S301
3. Louis N.A., Hamilton K.E., and Colgan S.P. Lipid mediator networks and leukocyte transmigration. Prostaglandins Leukot. Essent. Fatty Acids 73 (2005) 197-202
4. Matsumoto K., Taki F., Kondoh Y., Taniguchi H., and Takagi K. Platelet-activating factor in bronchoalveolar lavage fluid of patients with adult respiratory distress syndrome. Clin. Exp. Pharmacol. Physiol. 19 (1992) 509-515
5. Chang S.W., Feddersen C.O., Henson P.M., and Voelkel N.F. Platelet-activating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats. J. Clin. Invest. 79 (1987) 1498-1509
6. Byrne K., Sessler C.N., Carey P.D., Sielaff T.D., Vasquez A., Tatum J.L., Hirsch J.I., and Sugerman H.J. Platelet-activating factor in porcine pseudomonas acute lung injury. J. Surg. Res. 50 (1991) 111-118
7. Nagase T., Ishii S., Kume K., Uozumi N., Izumi T., Ouchi Y., and Shimizu T. Platelet-activating factor mediates acid-induced lung injury in genetically engineered mice. J. Clin. Invest. 104 (1999) 1071-1076
8. Castro Faria Neto H.C., Stafforini D.M., Prescott S.M., and Zimmerman G.A. Regulating inflammation through the anti-inflammatory enzyme platelet-activating factor-acetylhydrolase. Mem. Inst. Oswaldo Cruz 100 (2005) 83-91
9. Gomes R.N., Bozza F.A., Amancio R.T., Japiassu A.M., Vianna R.C., Larangeira A.P., Gouvea J.M., Bastos M.S., Zimmerman G.A., Stafforini D.M., Prescott S.M., Bozza P.T., and Castro-Faria-Neto H.C. Exogenous platelet-activating factor acetylhydrolase reduces mortality in mice with systemic inflammatory response syndrome and sepsis. Shock 26 (2006) 41-49
10. Triggiani M., De Marino V., Sofia M., Faraone S., Ambrosio G., Carratù L., and Marone G. Characterization of platelet-activating factor acetylhydrolase in human bronchoalveolar lavage. Am. J. Respir. Crit. Care Med. 156 (1997) 94-100
11. Nakos G., Pneumatikos J., Tsangaris I., Tellis C., and Lekka M. Proteins and phospholipids in BAL from patients with hydrostatic pulmonary edema. Am. J. Respir. Crit. Care Med. 155 (1997) 945-951
12. Grissom C.K., Orme Jr. J.F., Richer L.D., McIntyre T.M., Zimmerman G.A., and Elstad M.R. Platelet-activating factor acetylhydrolase is increased in lung lavage fluid from patients with acute respiratory distress syndrome. Crit. Care Med. 31 (2003) 770-775
13. Zimmerman G.A. Plasma platelet-activating factor acetylhydrolase is a dynamic variable in critical illness: in the end, is change good for you?. Crit. Care Med. 33 (2005) 1462-1463
14. Jandre F.C., Pino A.V., Lacorte I., Neves J.H., and Giannella-Neto A. A closed-loop mechanical ventilation controller with explicit objective functions. IEEE. Trans. Biomed. Eng. 51 (2004) 823-831
15. Kollef M.H., and Ward S. The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia. Chest 113 (1998) 412-420
16. Pacheco P., Bozza F.A., Gomes R.N., Bozza M., Weller P.F., Castro-Faria-Neto H.C., and Bozza P.T. Lipopolysaccharide-induced leukocyte lipid body formation in vivo: innate immunity elicited intracellular Loci involved in eicosanoid metabolism. J. Immunol. 169 (2002) 6498-6506
17. Bozza P.T., Melo R.C.N., and Bandeira-Melo C. Leukocyte lipid bodies regulation and function: contribution to allergy and host defense. Pharmacol. Ther. 113 (2007) 30-49
18. Zhou Z., Kozlowski J., and Schuster D.P. Physiologic, biochemical, and imaging characterization of acute lung injury in mice. Am. J. Respir. Crit. Care Med. 172 (2005) 344-351
19. Nakos G., Kitsiouli E., Hatzidaki E., Koulouras V., Touqui L., and Lekka M.E. Phospholipases A2 and platelet-activating-factor acetylhydrolase in patients with acute respiratory distress syndrome. Crit. Care Med. 33 (2005) 772-779
20. Nakos G., Tsangaris H., Liokatis S., Kitsiouli E., and Lekka M.E. Ventilator-associated pneumonia and atelectasis: evaluation through bronchoalveolar lavage fluid analysis. Intensive Care Med. 29 (2003) 555-563
21. Karagiorga G., Nakos G., Galiatsou E., and Lekka M.E. Biochemical parameters of bronchoalveolar lavage fluid in fat embolism. Intensive Care Med. 32 (2006) 116-123
22. Nakos G., Tsangaris I., and Lekka M.E. Platelet-activating factor acetylhydrolase and acute respiratory distress syndrome: unanswered questions. Crit. Care Med. 32 (2004) 1434-1435
23. Nakos G., Kitsiouli E.I., Tsangaris I., and Lekka M.E. Bronchoalveolar lavage fluid characteristics of early intermediate and late phases of ARDS, alterations in leukocytes, proteins, PAF and surfactant components. Intensive Care Med. 24 (1998) 296-303
24. Stafforini D.M., Elstad M.R., McIntyre T.M., Zimmerman G.A., and Prescott S.M. Human macrophages secrete platelet-activating factor acetylhydrolase. J. Biol. Chem. 265 (1990) 9682-9687
25. Jehle R., Schlame M., Buttner C., Frey B., Sinha P., and Rustow B. Platelet-activating factor (PAF)-acetylhydrolase and PAF-like compounds in the lung: effects of hyperoxia. Biochim. Biophys. Acta. 1532 (2001) 60-66
26. Claus R.A., Russwurm S., Dohrn B., Bauer M., and Losche W. Plasma platelet-activating factor acetylhydrolase activity in critically ill patients. Crit. Care Med. 33 (2005) 1416-1419
27. Opal S., Laterre P.F., Abraham E., Francois B., Wittebole X., Lowry S., Dhainaut J.F., Warren B., Dugernier T., Lopez A., Sanchez M., Demeyer I., Jauregui L., Lorente J.A., McGee W., Reinhart K., Kljucar S., Souza S., and Pribble J. Recombinant human platelet-activating factor acetylhydrolase for treatment of severe sepsis: results of a phase III, multicenter, randomized, double-blind, placebo-controlled, clinical trial. Crit. Care Med. 32 (2004) 332-341